Poland’s biopharma sector is best known for its strengths in generics and biosimilars, with companies like Polpharma SA providing central Europe and beyond with a reliable flow of affordable off-patent medications. However, some established companies are now developing innovative medicines, and a small list of biotech companies are creating the groundwork for a nascent biotech ecosystem.
The shift towards an innovative medicines sector has been gradual. Some generic drug manufacturers, like Celon Pharma S.A., have...
